Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,711 | -16,802 | -8,569 | -30,005 | -20,983 |
| Depreciation Amortization | 21 | 16 | 8 | 31 | 23 |
| Accounts payable and accrued liabilities | -1,252 | -977 | -370 | 836 | 425 |
| Other Working Capital | 825 | 1,425 | -222 | 4,938 | 4,716 |
| Other Operating Activity | -19,689 | 6,307 | 3,059 | 9,416 | 7,025 |
| Operating Cash Flow | $-14,384 | $-10,032 | $-6,094 | $-14,785 | $-8,793 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 20,000 | 20,000 |
| Other Financing Activity | 0 | 0 | 0 | -396 | -396 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $19,604 | $19,604 |
| Beginning Cash Position | 41,013 | 41,013 | 41,013 | 36,194 | 36,194 |
| End Cash Position | 26,629 | 30,981 | 34,918 | 41,013 | 47,004 |
| Net Cash Flow | $-14,384 | $-10,032 | $-6,094 | $4,819 | $10,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,384 | -10,032 | -6,094 | -14,785 | -8,793 |
| Free Cash Flow | -14,384 | -10,032 | -6,094 | -14,785 | -8,793 |